ISRCTN59376582
Completed
未知
Prospective, multicentric, longitudinal study to determine predictors of outcome in mechanically ventilated critically ill patients
niversity Hospital of Basel0 sites961 target enrollmentOctober 31, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Hospital of Basel
- Enrollment
- 961
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37076881/ (added 20/04/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Critically ill patients at the start of invasive mechanical ventilation
- •2\. Estimated to require continuous ventilatory support for longer than 24 hours or if already ventilated for 12 to maximal 36 hours.
- •3\. 18 years of age or older
Exclusion Criteria
- •1\. Pregnancy
- •2\. Patients with pre\-existing mental disorder precluding proper informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Observational study to evaluate PD-L1 protein expression in Chinese patients with advanced esophageal cancers and head and neck squamous cell carcinomaEsophageal cancer and head and neck squamous cell carcinomaCancerISRCTN10570964Merck Sharp and Dohme (China)920
Completed
Not Applicable
Assessment of the performance of a deep learning system at identifying breast cancer on screening mammograms using de-identified historic data.Breast cancerCancerISRCTN18056078Kheiron Medical Technologies1,000,000
Completed
Not Applicable
Oral furosemide and hydrochlorothiazide/amiloride versus intravenous furosemide for the treatment of nephrotic edemaISRCTN28785798Institutul Clinic Fundeni22
Completed
Not Applicable
Evaluation of the WOUNDCHEK point-of-care test for infection in the management of foot and leg ulcersChronic ulcer wounds of the legs and feetSkin and Connective Tissue DiseasesISRCTN11300898orth Cumbria Integrated Care NHS Foundation Trust131
Completed
Phase 3
A prospective, phase III, controlled, multicentre, randomised clinical trial comparing combination gemcitabine and capecitabine therapy with concurent and sequential chemoimmunotherapy using a telomerase vaccine in locally advanced and metastatic pancreatic cancerocally advanced and metastatic pancreatic cancerCancerLocally advanced and metastatic pancreatic cancerISRCTN43482138The University of Liverpool (UK)1,062